Aridis Pharmaceuticals In...

OTC: ARDS · Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Apr 01, 2025, 9:51 AM

Aridis Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-30.37M -42.19M
Depreciation & Amortization
487K 435K
Stock-Based Compensation
1.48M 2.25M
Other Working Capital
2.63M 7.86M
Other Non-Cash Items
577K 6.78M
Deferred Income Tax
n/a -722K
Change in Working Capital
-1.3M 10.52M
Operating Cash Flow
-29.13M -22.94M
Capital Expenditures
-82K -530K
Cash Acquisitions
n/a n/a
Purchase of Investments
n/a n/a
Sales Maturities Of Investments
n/a n/a
Other Investing Acitivies
n/a n/a
Investing Cash Flow
-82K -530K
Debt Repayment
3.2M 5M
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a -4.13M
Other Financial Acitivies
-1.03M 4.13M
Financial Cash Flow
14.78M 34.72M
Net Cash Flow
-14.43M 11.25M
Free Cash Flow
-29.21M -23.47M